+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Therapeutics Market by Application, Product Type, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4656184
  • Report
  • January 2020
  • Region: Global
  • 239 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 2MORROW Inc.
  • Livongo Health Inc.
  • Medtronic Plc.
  • Omada Health Inc.
  • Pear Therapeutics Inc.
  • Voluntis Inc.
  • MORE
The global digital therapeutics market was valued at $2,238 million in 2018 and is expected to reach $9,640 million by 2026 with a CAGR of 19.9% during the forecast period. Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.

the increase in the adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.9% from 2019 to 2026. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.

The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS

By Application
  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others
By Product Type
  • Software
  • Device
  • By Product Type
  • Business-to-Business (B2B)
  • Employer
  • Healthcare Provider
  • Others
  • Business-to-Consumer (B2C)
  • Patient
  • Caregiver
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 2MORROW Inc.
  • Livongo Health Inc.
  • Medtronic Plc.
  • Omada Health Inc.
  • Pear Therapeutics Inc.
  • Voluntis Inc.
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models

Chapter 2: Executive Summary
2.1. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2018
3.3. Porter's Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. the increase in the adoption of Smartphones And Tablets Coupled With Healthcare Apps
3.4.1.2. Growth In Need To Control Healthcare Costs
3.4.1.3. Rise In Incidence of Chronic Diseases
3.4.2. Restraints
3.4.2.1. Lack of Awareness Regarding Digital Therapeutics In Developing Countries
3.4.2.2. Patient Data Privacy Concerns
3.4.3. Opportunity
3.4.3.1. Emerging Markets offer Significant Growth Opportunities

Chapter 4: Digital Therapeutics Market, By Application
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Diabetes
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country
4.3. Obesity
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country
4.4. Cardiovascular Diseases
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast
4.4.3. Market Analysis, By Country
4.5. Central Nervous System (Cns) Diseases
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6. Gastrointestinal Disorder
4.6.1. Key Market Trends And Growth Opportunities
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7. Respiratory Diseases
4.7.1. Key Market Trends And Growth Opportunities
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8. Smoking Cessation
4.8.1. Key Market Trends And Growth Opportunities
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
4.9. Others
4.9.1. Key Market Trends And Growth Opportunities
4.9.2. Market Size And Forecast
4.9.3. Market Analysis, By Country

Chapter 5: Digital Therapeutics Market, By Product
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Software
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Devices
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country

Chapter 6: Digital Therapeutics Market, By Sales Channel
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Business-To-Business (B2B)
6.2.1. Market Size And Forecast, By Type
6.2.2. Employer
6.2.2.1. Market Size And Forecast
6.2.3. Healthcare Providers
6.2.3.1. Market Size And Forecast
6.2.4. Others
6.2.4.1. Market Size And Forecast
6.2.5. Market Size And Forecast, By Region
6.2.6. Market Analysis, By Country
6.3. Business-To-Consumers
6.3.1. Market Size And Forecast, By Type
6.3.2. Patients
6.3.2.1. Market Size And Forecast
6.3.3. Caregivers
6.3.3.1. Market Size And Forecast
6.3.4. Market Size And Forecast, By Region
6.3.5. Market Analysis, By Country

Chapter 7: Digital Therapeutics Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. North America Digital Therapeutics Market, By Country
7.2.2.1. U.S. Digital Therapeutics Market, By Application
7.2.2.2. U.S Digital Therapeutics Market, By Product Type
7.2.2.3. U.S. Digital Therapeutics Market, By Sales Channel
7.2.2.4. Canada Digital Therapeutics Market, By Application
7.2.2.5. Canada Digital Therapeutics Market, By Product Type
7.2.2.6. Canada Digital Therapeutics Market, By Sales Channel
7.2.2.7. Mexico Digital Therapeutics Market, By Application
7.2.2.8. Mexico Digital Therapeutics Market, By Product Type
7.2.2.9. Mexico Digital Therapeutics Market, By Sales Channel
7.2.3. North America Digital Therapeutics Market, By Application
7.2.4. North America Digital Therapeutics Market, By Product Type
7.2.5. North America Digital Therapeutics Market, By Sales Channel
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Europe Digital Therapeutics Market, By Country
7.3.2.1. UK Digital Therapeutics Market, By Application
7.3.2.2. UK Digital Therapeutics Market, By Product Type
7.3.2.3. UK Digital Therapeutics Market, By Sales Channel
7.3.2.4. Germany Digital Therapeutics Market, By Application
7.3.2.5. Germany Digital Therapeutics Market, By Product Type
7.3.2.6. Germany Digital Therapeutics Market, By Sales Channel
7.3.2.7. France Digital Therapeutics Market, By Application
7.3.2.8. France Digital Therapeutics Market, By Product Type
7.3.2.9. France Digital Therapeutics Market, By Sales Channel
7.3.2.10. Italy Digital Therapeutics Market, By Application
7.3.2.11. Italy Digital Therapeutics Market, By Product Type
7.3.2.12. Italy Digital Therapeutics Market, By Sales Channel
7.3.2.13. Spain Digital Therapeutics Market, By Application
7.3.2.14. Spain Digital Therapeutics Market, By Product Type
7.3.2.15. Spain Digital Therapeutics Market, By Sales Channel
7.3.2.16. Rest of Europe Digital Therapeutics Market, By Application
7.3.2.17. Rest of Europe Digital Therapeutics Market, By Product Type
7.3.2.18. Rest of Europe Digital Therapeutics Market, By Sales Channel
7.3.3. Europe Digital Therapeutics Market, By Application
7.3.4. Europe Digital Therapeutics Market, By Product Type
7.3.5. Europe Digital Therapeutics Market, By Sales Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Asia-Pacific Digital Therapeutics Market, By Country
7.4.2.1. Japan Digital Therapeutics Market, By Application
7.4.2.2. Japan Digital Therapeutics Market, By Product Type
7.4.2.3. Japan Digital Therapeutics Market, By Sales Channel
7.4.2.4. China Digital Therapeutics Market, By Application
7.4.2.5. China Digital Therapeutics Market, By Product Type
7.4.2.6. China Digital Therapeutics Market, By Sales Channel
7.4.2.7. Australia Digital Therapeutics Market, By Application
7.4.2.8. Australia Digital Therapeutics Market, By Product Type
7.4.2.9. Australia Digital Therapeutics Market, By Sales Channel
7.4.2.10. India Digital Therapeutics Market, By Application
7.4.2.11. India Digital Therapeutics Market, By Product Type
7.4.2.12. India Digital Therapeutics Market, By Sales Channel
7.4.2.13. South Korea Digital Therapeutics Market, By Application
7.4.2.14. South Korea Digital Therapeutics Market, By Product Type
7.4.2.15. South Korea Digital Therapeutics Market, By Sales Channel
7.4.2.16. Rest of Asia-Pacific Digital Therapeutics Market, By Application
7.4.2.17. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type
7.4.2.18. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel
7.4.3. Asia-Pacific Digital Therapeutics Market, By Application
7.4.4. Asia-Pacific Digital Therapeutics Market, By Product Type
7.4.5. Asia-Pacific Digital Therapeutics Market, By Sales Channel
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. LAMEA Digital Therapeutics Market, By Country
7.5.2.1. Brazil Digital Therapeutics Market, By Application
7.5.2.2. Brazil Digital Therapeutics Market, By Product Type
7.5.2.3. Brazil Digital Therapeutics Market, By Sales Channel
7.5.2.4. Turkey Digital Therapeutics Market, By Application
7.5.2.5. Turkey Digital Therapeutics Market, By Product Type
7.5.2.6. Turkey Digital Therapeutics Market, By Sales Channel
7.5.2.7. Saudi Arabia Digital Therapeutics Market, By Application
7.5.2.8. Saudi Arabia Digital Therapeutics Market, By Product Type
7.5.2.9. Saudi Arabia Digital Therapeutics Market, By Sales Channel
7.5.2.10. South Africa Digital Therapeutics Market, By Application
7.5.2.11. South Africa Digital Therapeutics Market, By Product Type
7.5.2.12. South Africa Digital Therapeutics Market, By Sales Channel
7.5.2.13. Rest of LAMEA Digital Therapeutics Market, By Application
7.5.2.14. Rest of LAMEA Digital Therapeutics Market, By Product Type
7.5.2.15. Rest of LAMEA Digital Therapeutics Market, By Sales Channel
7.5.3. LAMEA Digital Therapeutics Market, By Application
7.5.4. LAMEA Digital Therapeutics Market, By Product Type
7.5.5. LAMEA Digital Therapeutics Market, By Sales Channel

Chapter 8: Company Profiles
8.1. 2Morrow, Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments
8.2. Fitbit, Inc. (Twine Health, Inc.)
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Product Portfolio
8.2.4. Business Performance
8.2.5. Key Strategic Moves And Developments
8.3. Livongo Health, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Product Portfolio
8.3.4. Key Strategic Moves And Developments
8.4. Medtronic Plc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.4.6. Key Strategic Moves And Developments
8.5. Omada Health, Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Key Strategic Moves And Developments
8.6. Pear Therapeutics, Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Product Portfolio
8.6.4. Key Strategic Moves And Developments
8.7. Proteus Digital Health, Inc.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Key Strategic Moves And Developments
8.8. Resmed, Inc. (Propeller Health)
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves And Developments
8.9. Voluntis, Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.9.6. Key Strategic Moves And Developments
8.10. Welldoc, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Key Strategic Moves And Developments
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • 2MORROW Inc.
  • Livongo Health Inc.
  • Medtronic Plc.
  • Omada Health Inc.
  • Pear Therapeutics Inc.
  • Voluntis Inc.
  • MORE
According to the report, titled, ' Digital Therapeutics Market by Application, Product, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global digital therapeutics market size was valued at $2.24 billion in 2018 and is projected to reach $9.64 billion by 2026, growing at a CAGR of 19.9% from 2019 to 2026. The diabetes segment accounted more than one-fifth of the total market share in 2018.

Rise in utilization of smart devices and smartphones & tablets coupled with an increase in incidence of chronic diseases boosts the growth of the global market. However, lack of awareness toward healthcare-associated applications and an increase in concerns regarding patient data restrict the market growth. Conversely, high growth potential in the emerging markets offers lucrative opportunities for key market players operating in this segment.

Among applications, obesity segment is expected to grow at a significant CAGR of 22.5% during the forecast period, owing to increase in obese population worldwide. For instance, according to the WHO, as of 2016, about 39% of the adults in the age group of 18 years and above were overweight, globally.

Among products, in 2018, software segment held a dominant portion in the market, accounting for about two-thirds share of the global market. This is attributed to increased penetration of smartphones and other devices in the developing economies, which in turn increases the usage of healthcare applications.

Key Findings of the Study
Software is expected to be one of the most lucrative segments, registering a CAGR of 20.0% during the forecast period.
The business-to-consumers (B2C) segment accounted for maximum share in the global market in 2018, and is expected to grow at a CAGR of 20.3% during the forecast period.
U.S. dominated the North America digital therapeutics market, and is projected to retain this trend throughout the forecast period.
India is expected to exhibit the highest growth in the Asia-Pacific digital therapeutics market, registering a CAGR of 25.7% during the forecast period.
Saudi Arabia is expected to witness the highest growth in the LAMEA digital therapeutics market, growing at a CAGR of 23.2% during the forecast period.
In 2018, North America was the highest contributor to the market in terms of revenue, owing to increase in wellness trend and early adoption of novel technologies. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the presence of high populace countries such as India and China.

The key players operating in the global market are 2MORROW, Inc., Fitbit, Inc. (Twine Health, Inc.), Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc.

The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., Dthera Sciences.
Note: Product cover images may vary from those shown
4 of 5
  • 2MORROW Inc.
  • Fitbit Inc. (Twine Health Inc.)
  • Livongo Health Inc.
  • Medtronic Plc.
  • Omada Health Inc.
  • Pear Therapeutics Inc.
  • Proteus Digital Health Inc.
  • Resmed Inc. (Propeller Health)
  • Voluntis Inc.
  • Welldoc Inc.
Note: Product cover images may vary from those shown
5 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll